Bristol-Myers Squibb Company (BMY) Insider Trading
- $16,128,860.71
- $516,791,419.91
- Nov. 4, 2024
- Lamberto Andreotti
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 4, 2024 | SVP | 700 | $55.62 | Sell | $38,934.00 | |
| Nov. 1, 2024 | EVP | 1,830 | $54.67 | Buy | $100,046.10 | |
| Dec. 5, 2023 | CEO | 2,000 | $49.78 | Buy | $99,560.00 | |
| Nov. 28, 2023 | CEO | 3,071 | $48.86 | Buy | $150,049.06 | |
| Nov. 20, 2023 | Director | 8,500 | $49.81 | Buy | $423,385.00 | |
| Aug. 24, 2023 | EVP | 17,986 | $61.25 | Sell | $1,101,642.50 | |
| Aug. 3, 2023 | EVP | 732 | $61.14 | Sell | $44,754.48 | |
| May 3, 2023 | EVP | 50,385 | $67.06 | Sell | $3,378,818.10 | |
| Feb. 6, 2023 | CEO | 240,000 | $74.65 | Sell | $17,916,000.00 | |
| Feb. 6, 2023 | EVP | 11,183 | $74.69 | Sell | $835,258.27 | |
| Nov. 9, 2022 | EVP | 16,250 | $80.45 | Sell | $1,307,312.50 | |
| Nov. 7, 2022 | EVP | 45,910 | $78.88 | Sell | $3,621,380.80 | |
| Sept. 20, 2022 | CEO | 25,000 | $69.71 | Sell | $1,742,750.00 | |
| Sept. 15, 2022 | CEO | 50,000 | $71.84 | Sell | $3,592,000.00 | |
| Sept. 14, 2022 | EVP | 25,000 | $70.75 | Sell | $1,768,750.00 | |
| Sept. 13, 2022 | CFO | 133,951 | $71.30 | Sell | $9,550,706.30 | |
| June 13, 2022 | CEO | 30,000 | $74.04 | Sell | $2,221,200.00 | |
| June 6, 2022 | EVP | 65,000 | $74.89 | Sell | $4,867,850.00 | |
| March 21, 2022 | CEO | 25,000 | $71.52 | Sell | $1,788,000.00 | |
| March 16, 2022 | EVP | 74,559 | $69.25 | Sell | $5,163,210.75 | |
| March 14, 2022 | EVP | 29,532 | $69.20 | Sell | $2,043,614.40 | |
| March 14, 2022 | SVP | 6,577 | $69.19 | Sell | $455,062.63 | |
| Feb. 24, 2022 | CEO | 30,000 | $67.00 | Sell | $2,010,000.00 | |
| Nov. 24, 2021 | EVP | 17,353 | $56.92 | Sell | $987,732.76 | |
| Nov. 22, 2021 | EVP | 18,363 | $57.17 | Sell | $1,049,812.71 | |
| Sept. 20, 2021 | CEO | 25,000 | $60.64 | Sell | $1,516,000.00 | |
| Aug. 12, 2021 | CFO | 99,691 | $66.95 | Sell | $6,674,312.45 | |
| May 10, 2021 | SVP | 1,118 | $65.00 | Sell | $72,670.00 | |
| May 10, 2021 | EVP | 15,000 | $65.25 | Sell | $978,750.00 | |
| May 5, 2021 | EVP | 30,546 | $64.29 | Sell | $1,963,802.34 | |
| May 5, 2021 | SVP | 3,119 | $64.21 | Sell | $200,270.99 | |
| March 22, 2021 | CEO | 25,000 | $62.20 | Sell | $1,555,000.00 | |
| Nov. 25, 2020 | EVP | 3 | $63.50 | Sell | $190.50 | |
| Nov. 24, 2020 | SVP | 900 | $63.39 | Sell | $57,051.00 | |
| Nov. 23, 2020 | EVP | 13,421 | $61.34 | Sell | $823,244.14 | |
| Nov. 19, 2020 | EVP | 57,591 | $61.30 | Sell | $3,530,328.30 | |
| Aug. 31, 2020 | CEO | 39,840 | $62.70 | Sell | $2,497,968.00 | |
| Aug. 17, 2020 | SVP | 5,327 | $64.00 | Sell | $340,928.00 | |
| Aug. 13, 2020 | EVP | 141,420 | $63.24 | Sell | $8,943,400.80 | |
| June 15, 2020 | Director | 9,174 | $54.50 | Buy | $499,983.00 | |
| May 22, 2020 | SVP | 3,200 | $61.01 | Sell | $195,232.00 | |
| May 19, 2020 | EVP | 25,000 | $62.68 | Sell | $1,567,000.00 | |
| March 4, 2020 | EVP | 15,805 | $61.01 | Sell | $964,263.05 | |
| Nov. 5, 2019 | Insider | 25,000 | $56.56 | Sell | $1,414,000.00 | |
| Nov. 5, 2019 | SVP | 15,000 | $56.66 | Sell | $849,900.00 | |
| Sept. 18, 2019 | Insider | 11,338 | $98.27 | Sell | $1,114,185.26 | |
| July 31, 2019 | Director | 11,000 | $44.72 | Buy | $491,920.00 | |
| May 16, 2019 | Director | 5,000 | $47.29 | Buy | $236,450.00 | |
| May 16, 2019 | Insider | 3,065 | $47.56 | Sell | $145,771.40 | |
| Feb. 12, 2019 | Director | 2,000 | $89.99 | Buy | $179,980.00 |
Insiders are both buying and selling Bristol-Myers Squibb Company stock.
The insider traders at Bristol-Myers Squibb Company are: Lamberto Andreotti, Giovanni Caforio, Gilla Kaplan, James M Cornelius, Ernest Mario, Rupert Vessey, Sandra Leung, Louis S Schmukler, Joseph C Caldarella, James J Loughlin, Michael D Casey, Autenried Paul Von, John E Elicker, Theodore R Samuels II, Robert J Hugin, Ann Powell, Samuel J Moed, Charles A Bancroft, Beatrice J Cazala, Adam Dubow, Mark J Alles, Michael A Friedman, Christopher S Boerner, Joseph Eid, Karen Murphy Santiago, David V Elkins, Lewis B Campbell, Dinesh C Paliwal, Louis Schmukler, Perry A Karsen, James Cornelius, Michael D. Casey, Thomas O Daniel, Terrie Curran, Richard W Barker, Joseph Caldarella, Francis M Cuss, Samit Hirawat, Carrie Smith Cox, Charles Bancroft, Corp /De/ Celgene, Elliot Sigal, Francis Cuss, John Elicker, John H Weiland, Lawrence Stein, Lawrence V Stein, Lewis Campbell, Michael Casey, Michael W Bonney, Perry Karsen, Phil M Holzer, Robert J Bertolini, Robert M Plenge, Thomas Daniel, and Thomas J Jr. Lynch
The most active insider trader at Bristol-Myers Squibb Company is Lamberto Andreotti with 27 trades.
Robert J Hugin has sold the most Bristol-Myers Squibb Company stock with a total value of $90,990,863.06.
Corp /De/ Celgene has bought the most Bristol-Myers Squibb Company stock with a total value of $22,404,200.00.
The most recent insider trade for Bristol-Myers Squibb Company was on Nov. 4, 2024.
The single biggest insider buy for Bristol-Myers Squibb Company was from Corp /De/ Celgene with a total value of $11,202,100.00 on Oct. 24, 2016.
The single biggest insider sell for Bristol-Myers Squibb Company was from Robert J Hugin with a total value of $23,604,615.80 on June 22, 2017.